Expert presentation

<5 minutes

The Chronic Burden of Type 2 Inflammatory Diseases

Topic: Burden Of Disease Pathophysiology

Tags: Pathophysiology  Quality of Life  Diagnosis  Epidemiology 

The Chronic Burden of Type 2 Inflammatory Diseases

Dr. Raj Chovatiya highlights the impact of type 2 inflammation on clinical consequences associated with atopic dermatitis, prurigo nodularis, chronic spontaneous urticaria, asthma, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis

MAT-US-23041445 V1.0 Exp Date: 05/30/2025

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM